Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Aug;27(8):967.
doi: 10.1080/13543776.2017.1341018. Epub 2017 Jun 20.

Highly selective A3 adenosine receptor agonists relieve chronic neuropathic pain

Daniela Salvemini  1 , Kenneth A Jacobson  2
Affiliations
Comment

Highly selective A3 adenosine receptor agonists relieve chronic neuropathic pain

Daniela Salvemini et al. Expert Opin Ther Pat. 2017 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

Daniela Salvemini has a financial interest in Biointervene.

Comment in

Comment on

References

    1. do Couto Maia R. Recent trends in neuropathic pain patents. Expert Opin Ther Pat. 2017;27:539–546. doi: 10.1080/13543776.2017.1273349. - DOI - PubMed
    1. Pina LTS, Gouveia DN, Costa JS, et al. New perspectives for chronic pain treatment: a patent review (2010–2016) Expert Opin Ther Pat. 2017;27:787–796. doi: 10.1080/13543776.2017.1297425. - DOI - PubMed
    1. Janes K, Jacobson KA, Symons-Liguori AM, et al. Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol. 2016;173:1253–1267. - PMC - PubMed
    1. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107. - PubMed
    1. Chen Z, Janes K, Chen C, et al. Controlling murine and rat chronic pain through A3 adenosine receptor activation. Faseb J. 2012;26:1855–1865. - PMC - PubMed

Substances

LinkOut - more resources